125 related articles for article (PubMed ID: 37766076)
1. Anti-S and Anti-N Antibody Responses of COVID-19 Vaccine Recipients.
Al-Shudifat AE; Al-Tamimi M; Dawoud R; Alkhateeb M; Mryyian A; Alahmad A; Abbas MM; Qaqish A
Vaccines (Basel); 2023 Aug; 11(9):. PubMed ID: 37766076
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.
Sughayer MA; Souan L; Abu Alhowr MM; Al Rimawi D; Siag M; Albadr S; Owdeh M; Al Atrash T
Vaccine; 2022 May; 40(20):2841-2847. PubMed ID: 35397946
[TBL] [Abstract][Full Text] [Related]
3. Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers.
Alqassieh R; Suleiman A; Abu-Halaweh S; Santarisi A; Shatnawi O; Shdaifat L; Tarifi A; Al-Tamimi M; Al-Shudifat AE; Alsmadi H; Al Sharqawi A; Alnawaiseh H; Anasweh Y; Domaidah FA; Jaber HA; Al-Zarir MR; Bsisu I
Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835153
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq.
Majed SO
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):103-112. PubMed ID: 37300682
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune response to COVID-19 infection or vaccination among celiac disease patients.
Albatayneh E; Alabdallat Y; Kreishan E; Ayash H; Abu-Lubad M
Cent Eur J Immunol; 2022; 47(3):267-274. PubMed ID: 36817269
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Antinucleocapsid Antibody Response of mRNA and Inactivated Virus Vaccines Compared to Unvaccinated Individuals.
Qaqish A; Abbas MM; Al-Tamimi M; Abbas MA; Al-Omari M; Alqassieh R
Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632399
[TBL] [Abstract][Full Text] [Related]
7. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of post-vaccination immunoglobulin G antibodies and T-cell immune response after inoculation with different types and doses of SARS-CoV-2 vaccines: A retrospective cohort study.
Al-Rifai RH; Alhosani F; Abuyadek R; Atef S; Donnelly JG; Leinberger-Jabari A; Ahmed LA; Altrabulsi B; Alatoom A; Alsuwaidi AR; AbdelWareth L
Front Med (Lausanne); 2022; 9():1092646. PubMed ID: 36703898
[TBL] [Abstract][Full Text] [Related]
9. [Comparative Analyses of IgA Antibody Response of Non-COVID-19 Infected People Over 60 Years Old Following CoronaVac and Pfizer-BioNTech COVID-19 Vaccination].
Yürüker Ö; Yetkin O; Güvenir M
Mikrobiyol Bul; 2023 Apr; 57(2):330-333. PubMed ID: 37067217
[TBL] [Abstract][Full Text] [Related]
10. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar.
Bansal D; Atia H; Al Badr M; Nour M; Abdulmajeed J; Hasan A; Al-Hajri N; Ahmed L; Ibrahim R; Zamel R; Mohamed A; Pattalaparambil H; Daraan F; Chaudhry A; Oraby S; El-Saleh S; El-Shafie SS; Al-Farsi AF; Paul J; Ismail A; Al-Romaihi HE; Al-Thani MH; Doi SAR; Zughaier SM; Cyprian F; Farag E; Farooqui HH
Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992080
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals.
Al-Tamimi M; Tarifi AA; Qaqish A; Abbas MM; Albalawi H; Abu-Raideh J; Salameh M; Khasawneh AI
PLoS One; 2023; 18(2):e0281689. PubMed ID: 36787317
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study.
Sauré D; O'Ryan M; Torres JP; Zuñiga M; Soto-Rifo R; Valiente-Echeverría F; Gaete-Argel A; Neira I; Saavedra V; Acevedo ML; Archila C; Acuña F; Rain M; Basso LJ
Lancet Microbe; 2023 Mar; 4(3):e149-e158. PubMed ID: 36716754
[TBL] [Abstract][Full Text] [Related]
14. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
[TBL] [Abstract][Full Text] [Related]
15. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
[TBL] [Abstract][Full Text] [Related]
16. [COVID-19 infections and effectiveness of the vaccination among healthcare workers].
Rojkovich B; Németh D; Dinya E; Nagy E; Török E; Lázár I; Perduk A; Géher P; Nagy G
Orv Hetil; 2023 Feb; 164(5):163-171. PubMed ID: 36739547
[TBL] [Abstract][Full Text] [Related]
17. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm.
Anvari E; Ghamar Talepoor A; Eshkevar Vakili M; Karimi N; Ataollahi M; Najafi G; Kabelitz D; Ahmadi I; Kalantar K
Iran J Immunol; 2022 Sep; 19(3):321-329. PubMed ID: 36190385
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 anti immunoglobulin G antibodies serum levels among health care workers post COVID -19 vaccination: A single center study.
Saad SS; Omar WH; Attia FM; El Sayed AE; Eida MM; Nemr NA
Egypt J Immunol; 2023 Oct; 30(4):30-39. PubMed ID: 37787771
[TBL] [Abstract][Full Text] [Related]
20. Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 or Post-Vaccination in Libyan Population: Comparison of Four Vaccines.
Ebrahim F; Tabal S; Lamami Y; Alhudiri IM; El Meshri SE; Al Dwigen S; Arfa R; Alboeshi A; Alemam HA; Abuhtna F; Altrhouni R; Milad MB; Elgriw NA; Ruaua MA; Abusrewil Z; Harroush W; Jallul M; Ali FS; Eltaib F; Elzagheid A
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
